Clinical Trials Browser

Colorectal Neoplasms × Abituzumab × Clear all

NCT03688230 2020-03-18

AMELION

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT01008475 2016-03-30

POSEIDON

Phase 1/2 Completed

232 enrolled 20 charts

Gastrointestinal

Colorectal Neoplasms